Omthera Pharmaceuticals, Inc. (extinct)

Omthera Pharmaceuticals, Inc. (extinct)

Omthera Pharmaceuticals, Inc. (extinct)

Overview
Date Founded

2008

Headquarters

707 State Road, Princeton, NJ, 08540, USA

Type of Company

Private

Employees (Worldwide)

11 - 50

Industries

Pharmaceuticals
Hospitals & Patient Services
Medical Support Services
Biotechnology

Company Description

Omthera Pharmaceuticals, Inc. operates as pharmaceuticals company which focuses on the clinical development of new therapies for dyslipidemia. The company was founded by Jerry Wisler and Michael Davidson in 2008 and is headquartered in Princeton, NJ.

Contact Data
Trying to get in touch with decision makers at Omthera Pharmaceuticals, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Co-Founder, President & Chief Executive Officer

Founder & Chief Medical Officer

Paths to Omthera Pharmaceuticals, Inc.
Potential Connections via
Relationship Science
You
Omthera Pharmaceuticals, Inc.
Recent Transactions
Details Hidden

AstraZeneca Plc purchases Omthera Pharmaceuticals, Inc.

Details Hidden

Omthera Pharmaceuticals, Inc. issued USD Common Stock

Details Hidden

Omthera Pharmaceuticals, Inc. raised money in a private placement transaction

Transaction Clients
Investment Advisor

Advised on Bristol-Myers Squibb Company purchases Medarex, Inc.

Transaction Advisors
Underwriter

Advised onOmthera Pharmaceuticals, Inc. issued USD Common Stock

Underwriter

Advised onOmthera Pharmaceuticals, Inc. issued USD Common Stock

Legal Advisor

Advised onAstraZeneca Plc purchases Omthera Pharmaceuticals, Inc.

Associate

Advised onAstraZeneca Plc purchases Omthera Pharmaceuticals, Inc.

Associate

Advised onAstraZeneca Plc purchases Omthera Pharmaceuticals, Inc.

Legal Advisor

Advised onAstraZeneca Plc purchases Omthera Pharmaceuticals, Inc.

Advisors & Consultants
Legal Advisor

National Co-Chair, Life Sciences Practice at Goodwin Procter LLP

Key Stats and Financials As of
Market Capitalization
$325M
Total Enterprise Value
Earnings Per Share
Investors
Details Hidden

New Enterprise Associates seeks invests in companies located across the globe. The firm targets companies operating in the fields of technology (software & services, systems, consumer & internet, energy), healthcare (biopharms, devices, services). The firm provides financing for seed, early and growth stage capital requirements.

Details Hidden

Sofinnova Partners is an active manager which invests exclusively in life sciences and information technology firms in France, Europe, and to a limited extent, the US. They also have expertise in the clean technology sector. The firm aims to build companies from seed rounds to a trade sale or an IPO, investing in start-ups and early-stage companies with ambitious projects. They a minimum of 0.5 million euros per investment, and up to 20 million euros over several rounds of financing.Sofinnova acts as lead or co-lead investor, taking a seat on the board of directors and seeking to bring added value to the investee company management team.

Details Hidden

Director-Preventive Cardiology at The University of Chicago

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Omthera Pharmaceuticals, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Omthera Pharmaceuticals, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Omthera Pharmaceuticals, Inc..